Define Your Needs: Turn an Idea Into a Factory Brief

Define Your Needs: Turn a Vague Idea Into a Factory-Executable Brief

Define your needs before you ask a factory for a quote. Most supplement orders that go wrong started as a vague sentence, and the fix is a one-page brief a factory can actually price and make, not a longer email.

I’m an independent advisor paid by the buyer. I run my own biotech company, but I am not a factory and I don’t represent one. This guide is about helping you define your needs clearly, not about selling you anything.


01 Why define your needs before you contact a factory

Short answer

Define your supplement needs before you ask for quotes. A factory can make almost anything if the brief is clear, but it cannot guess your active form, your dose, or your target market. Those three anchors turn a vague idea into a brief suppliers can price and execute.

The cheapest place to fix a sourcing mistake is on paper, before anyone quotes you. In my experience the orders that blow up months later almost never start with a bad factory. They start with a brief that was never written. The buyer had a feeling, the supplier filled the silence with their most convenient stock SKU, and by the time the mismatch surfaced, tooling and deposits were already spent.

A factory is not a mind reader. It will gladly make what you describe, and if you describe nothing specific, it will make what it already makes. That isn’t dishonesty. It’s gravity: the supplier optimizes for what is easy to produce and easy to ship. Your job is to put your actual requirements on the table first, so “easy for them” and “right for you” are the same thing.

A vague brief creates three problems you feel later, not sooner:

  1. You get quotes that aren’t comparable. Each supplier silently assumes a different form, dose, or market, so the numbers you’re lining up aren’t measuring the same product.
  2. You lose leverage. You end up reacting to their proposal instead of testing it against your own spec. Once they’ve written the draft, you’re negotiating their document.
  3. You inherit rework. The form or market mismatch shows up after samples, or after a deposit, when fixing it costs real money and lead time.

The fix is not a longer email. It is deciding three things before you write to anyone.

Why it matters (impact): A vague brief doesn’t just slow you down. It hands the supplier the pen. The moment they write the spec, you are responding to their draft instead of your own requirement.


02 The three anchors a factory can’t guess

If you only do three things before quoting, do these. Form. Dose. Target market. Everything else a factory can propose. These three it cannot infer, and the pattern I keep seeing is that buyers who skip them pay for it twice.

Anchor 1: the exact active form

“Magnesium” is not a specification. Magnesium oxide, magnesium glycinate, and magnesium citrate are different compounds with different elemental magnesium per gram, different cost, different taste, and different fill requirements. Buyers who write “magnesium 200 mg” without naming the salt get three different products from three suppliers, then wonder why the quotes don’t line up.

The same trap lives in botanicals. An extract “standardized to 10%” means nothing until you name the marker compound and the test method. I’ve watched a buyer compare two “10% extracts” that were standardized to different markers, which means they were not the same material at all. The label number matched; the substance did not.

Buyer note (source B): Based on 20+ years on the production side of this industry, the single most common cause of non-comparable quotes is a form left unnamed. The factory doesn’t guess wrong on purpose. You simply never told it which compound you meant.

What to look at: Does your brief name the exact chemical or botanical identity, including the salt or the marker? If it says only the element or the plant, it is not a spec yet.

Anchor 2: the dose (strength per serving)

Dose is where form and math meet. “200 mg magnesium” as glycinate is not the same as “200 mg magnesium” as oxide, because the elemental amount differs by compound. The factory needs to know what number goes on your label, per what unit (per serving, per capsule, per sachet), and whether that number is elemental or as-the-salt.

This is also where a manufacturer’s own rule is useful to know (source A). Under FDA 21 CFR Part 111, a dietary supplement manufacturer must establish specifications for the identity, purity, strength, and composition of both components and finished product. In plain terms, the factory is already required to hold a spec. Your brief should state yours, so the two match and the claim on your label is the one actually being made.

What to ask: “What strength are you formulating to, and is that the elemental amount or the as-salt amount?” A supplier who can’t answer that cleanly is guessing at your label.

Anchor 3: the target market

Where you plan to sell decides what you are allowed to put in the bottle and on the label: permitted ingredients, maximum levels, and which claims are legal. A composition built for one market can be non-compliant in another, and a claim that is fine on one region’s label can be barred in the next.

The EU framework is a clean example (source A). Regulation (EC) No 1924/2006 governs nutrition and health claims across the EU, and a claim generally must be authorized after EFSA scientific assessment. A formula and a label built for one market don’t automatically travel. Your brief should name the market or markets up front, so the factory doesn’t propose a composition that can’t be labeled where you sell.

Buyer note: I am describing the type of rule that applies. I am not printing a list of permitted levels, because those change by market and by year. The working rule for your brief is simple: name the market, then check the latest rules for that market before you lock the formula.

What to look at: Is the target market named in your brief? If it says “I’ll decide the market later,” the factory will optimize for its home market, and you may be the one re-forming the product after the fact.


03 What a factory-executable brief actually contains

A brief isn’t a thesis. It’s a one-page set of decisions. Here is what a factory needs from you, and what you should deliberately leave open.

The fields a factory needs:

  • Product concept in one line: what it is and who it’s for. Not a benefit claim.
  • Active form, named exactly: the salt, the marker, the method. (See Anchor 1.)
  • Dose / strength: per serving and per unit, with elemental versus as-compound stated.
  • Dosage form: capsule, tablet, powder, sachet. Formulation guide covers the cost and compliance trade-offs; your brief just names the format.
  • Target market(s): named, not implied.
  • Expected volume / batch-size range: so they can quote realistically rather than quote a number built for a different order size.
  • Claims you intend, or a plain “no claims”: this is where the Compliance guide earns its place.
  • Must-avoid list: allergens, ingredients barred in your market, formats you won’t accept.

What to leave open on purpose:

  • Exact excipients: let the factory propose, then you review.
  • Packaging specifics, process details, equipment: as long as the spec is met.
  • Over-specifying the “how” is how buyers accidentally disqualify good factories or lock in a worse process than necessary.

Put those two lists side by side and the difference between a vague brief and a usable one is obvious:

Table 1: A vague brief versus a one-page brief a factory can execute
DimensionVague briefOne-page brief
What you sendA paragraph, or a link to a competitor’s productA one-page set of explicit decisions
What quotes you get backShaped to each supplier’s existing stockBuilt to your stated spec
Can you compare quotes?No, the assumptions differYes, the inputs are the same
Rework riskHigh, mismatch shows after samplesLow, mismatch caught on paper
Who controls the specThe supplierYou
LeverageYou react to their draftYou test their quote against your brief

Source note: the comparison reflects a buyer-side workflow, supported by the observation (source B) that unnamed form/dose is the most common cause of non-comparable quotes, and by the consensus (source C) that a competitor’s label is a starting point, not a factory-executable specification.


04 How to read a supplier’s first reaction to your brief

Sending the brief is half the work. Reading what comes back tells you more about the supplier than any brochure, and it costs you nothing but attention.

What to look at in the reply:

  • Do they ask sharp clarifying questions? A supplier who reads your brief and comes back with precise questions about your form, your dose math, or your market is showing they can execute a spec. That is a good signal, and it is rarer than it should be.
  • Do they immediately steer you to a stock SKU? If your clear brief gets a fast “we have something just like this,” slow down. Steering toward existing stock is efficient for them and not automatically bad for you, but it is a sign they’re optimizing their catalog, not your requirement.
  • Do the quotes actually answer the brief? Check that each quote names the same form, the same dose basis, and the same market. If they don’t, the quote isn’t comparable yet, no matter how tidy the PDF looks.

What to ask the factory (these are questions, not scripts):

  • “Can you produce this exact form at this strength for [market]?”
  • “What’s your typical excipient load for this format, and which ones do you default to?”
  • “Have you made this form for my target market before, and what compliance points should I plan for?”
  • “If I name the third-party lab, will you accept a batch-specific test against my spec?”

The move from a vague idea to a comparable quote is a short pipeline, and the three anchors are the middle steps that make it work:

Vague idea Define needs Form Dose Target market One-page brief Comparable quotes Skip any one anchor and the quotes you get back aren’t measuring the same thing.
A vague idea becomes a comparable quote only after the three anchors, form, dose, and target market, are fixed in a one-page brief. Leave any one of them open and suppliers fill it with their own assumptions.

Scope & boundary (warn): These are screening signals, not proof. A supplier can ask good questions and still be wrong on a detail, and a trader can memorize good questions. The brief’s job is to make the gaps visible so you can close them with documents and tests, not to convict anyone from one reply.


05 Common pitfalls when the brief stays vague

The mistakes repeat so often they’re worth naming directly.

  1. “I’ll let the factory advise me.” Advice is fine; abdicating the spec is not. The factory advises within your brief, not instead of it. A blank page just becomes their catalog.
  2. Confusing the element with the compound (form vs salt). Covered in Anchor 1, but it earns a second mention: it is the most common cause of non-comparable quotes, and it is completely avoidable.
  3. Skipping the target market. The most expensive one. Reformulating after the fact means new specs, new samples, and new lead time, none of which the original quote accounted for.
  4. Writing a benefit claim instead of a spec. “Helps with X” is not a brief. It is a claim, and claims are a compliance question for the Compliance guide, not a manufacturing input.

A pattern I keep seeing (source B): Buyers who skip the written spec almost always end up comparing a factory’s stock SKU against another factory’s stock SKU, then wondering why neither fits what they pictured. The picture was never written down.


06 From brief to confident quotes: your next step

You don’t need a 40-page document. You need three decisions written down, a one-page brief built from them, and a calm read of how suppliers respond. Define the form, the dose, and the market. Send the brief. Read the replies for clarifying questions, stock-SKU steering, and whether the quote actually answers your spec. Then, and only then, compare quotes that finally mean the same thing.

Before you brief a factory It helps to know you’re talking to the right entity first. See the Vet Suppliers guide for the document routine that proves a manufacturing entity, and the supplier request templates for how to phrase what you’re asking without giving away your product idea. For the form-and-dose math, [the Formulation guide](/guides/formulation-dosage-form/) goes deeper; for market rules, [the Compliance guide](/guides/compliance-certification/) maps certs to where you sell. Grab the free China Sourcing Pitfall Guide, the 9-step checklist I send buyers before every order.

Before you send the brief, run five questions over it. Each one is there because leaving it open is how a vague idea stays vague:

  • Is the exact active form named — the salt or the botanical marker, not just the element or plant?
  • Does the dose state strength per serving and per unit, and does it say whether that figure is elemental or as-compound?
  • Is the target market named now, rather than decided after the first quote arrives?
  • Is the dosage form specified, and are excipients deliberately left for the factory to propose?
  • Are claims stated as intended, or plainly marked “no claims”?

07 Scope and boundaries (what this guide covers — and what it won’t sign off)

This guide covers the buyer-side framework for defining your needs before you source: why a written brief protects you, the three anchors a factory can’t guess, what a one-page brief should contain, and how to read a supplier’s first reply. That is the “why” and the “what to look at.”

It does not cover the step-by-step “how to fill in a spec template” or the request scripts themselves. Those live in the free China Sourcing Pitfall Guide (our lead magnet, delivered by email, kept separate from the site so the site stays a clean reference). The point of this page is judgment, not paperwork.

And one hard line: I do not certify any supplier or any formulation as compliant for your market. Whether a specific composition is legal where you sell is a conclusion for the regulator and, where needed, a qualified compliance professional, not for an article and not for me by proxy. My job is to help you ask better questions and see the answers clearly.


Found this useful?

Grab the free China Sourcing Pitfall Guide — the 9-step checklist I send buyers before every order, including the “Define” step that turns a vague idea into a brief factories can execute.

Get the free guide

Written by Luo Gang — Independent China supplement & botanical sourcing advisor
20+ years across the health & nutrition industry; founder of my own biotech company (China), 10+ years — but not a factory, not a reseller. Native Chinese, based in China. I’ve worked the full chain from raw botanical extract to finished supplement, and I’m paid by buyers, not factories — no commissions.

Sources checked for this article

  • [A] FDA 21 CFR Part 111, §111.70. Manufacturers must establish specifications for identity, purity, strength, composition, and contamination limits for components and finished product. ecfr.gov
  • [A] EU Regulation (EC) No 1924/2006 on nutrition and health claims made on foods. EU-harmonized claims framework; claims require EFSA scientific assessment and Commission authorization. efsa.europa.eu
  • [B] “Buyers who skip a written spec get steered to the supplier’s stock SKU” and “unnamed form/dose is the most common cause of non-comparable quotes.” Based on 20+ years of first-hand sourcing and production observation; stated as experience, not a single public clause.
  • [C] “A competitor’s label is a starting point, not a factory-executable specification.” A point of broad agreement among sourcing guides, though wording and granularity differ; recorded as consensus, not a verified statute.
  • [D] Specific supplier names, license numbers, and exact per-market limit values are not given; market-specific rules are stated as “check the latest rules for your target market.”

How this was written: every claim is checked against the source listed above before publication. Single-source experiential items carry a “based on 20+ years” qualifier; where a standard’s clause text was not the point, only the standard name and a descriptive requirement appear. No clause number is printed where it would overstate what was verified.


FAQ

Q: What should a supplement brief include before I ask factories for quotes? A: Before you request quotes, your brief should name the exact active form (including the salt or botanical marker), the dose or strength per serving and per unit (stating elemental versus as-compound), the dosage form, your target market(s), an expected volume range, and any claims you intend or a plain “no claims.” Leave the exact excipients, packaging, and process to the factory, as long as your spec is met. A one-page brief like this is what makes supplier quotes comparable.

Q: Why does the exact active form matter as much as the dose? A: Because the form and the dose are linked by math. “200 mg magnesium” as glycinate is not the same as “200 mg magnesium” as oxide, since the elemental amount differs by compound. In botanicals, a “10% extract” is meaningless until you name the marker compound and the test method. If your brief names only the element or the plant, suppliers will silently assume different compounds, and the quotes you receive will not be measuring the same product.

Q: Do I need to decide my target market before contacting a supplier? A: Yes. Where you plan to sell decides what you are allowed to put in the bottle and on the label, including permitted ingredients, maximum levels, and which claims are legal. A composition built for one market may be non-compliant in another, and an EU health claim, for example, generally requires authorization after EFSA assessment under Regulation (EC) No 1924/2006. Naming the market in your brief stops the factory from optimizing for its home market and saves you from reformulating later.



Related: Vet Suppliers · Formulation & Dosage Form · Compliance & Certification · OEM / Private Label. Start with the free China Sourcing Pitfall Guide.

Independent advisor · On the buyer’s side.

Luo Gang

Independent China health-product sourcing advisor. Your “China eye” from spec to shipment.

© Luo Gang. All rights reserved. Independent advisor · On the buyer’s side.

Similar Posts